VC005 tablets

Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Pharmacokinetics of VC005 Tablets in Subjects With Hepatic Impairment and Normal Hepatic Function

A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata

A Study of VC005 Tablets in Adolescent Subjects With Non-Segmental Vitiligo

Efficacy and Safety Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata

Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.